Rock Springs Capital Management LP Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$4.0T
Holdings
135
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (135 positions)
| Stock | Value |
|---|---|
AGLAGILON HEALTH INC | $193.7B |
HUMHUMANA INC | $160.4B |
PODDINSULET CORP | $128.3B |
UNHUNITEDHEALTH GROUP INC | $122.4B |
IDXXIDEXX LABS INC | $119.7B |
ARGXARGENX SE | $110.4B |
NBIXNEUROCRINE BIOSCIENCES INC | $103.6B |
AFWALIGN TECHNOLOGY INC | $94.4B |
HCAHCA HEALTHCARE INC | $94.0B |
ISRGINTUITIVE SURGICAL INC | $90.1B |
HZNPHORIZON THERAPEUTICS PUB L | $78.5B |
AGIOAGIOS PHARMACEUTICALS INC | $77.6B |
EVHEVOLENT HEALTH INC | $76.9B |
PCRXPACIRA BIOSCIENCES INC | $76.3B |
IMCRIMMUNOCORE HLDGS PLC | $76.3B |
RAREULTRAGENYX PHARMACEUTICAL IN | $74.7B |
EWEDWARDS LIFESCIENCES CORP | $70.2B |
IRTCIRHYTHM TECHNOLOGIES INC | $68.7B |
ACRSACLARIS THERAPEUTICS INC | $66.6B |
FRPTFRESHPET INC | $60.8B |
2L9BLUEPRINT MEDICINES CORP | $60.5B |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $60.3B |
BAXBAXTER INTL INC | $58.2B |
SWAVUSDSHOCKWAVE MED INC | $56.3B |
KRTXKARUNA THERAPEUTICS INC | $54.8B |
ALNYALNYLAM PHARMACEUTICALS INC | $54.3B |
DC4DEXCOM INC | $53.2B |
ZLABZAI LAB LTD | $53.0B |
NVROEURNEVRO CORP | $52.2B |
ACHCACADIA HEALTHCARE COMPANY IN | $49.4B |
ASNDASCENDIS PHARMA A/S | $49.0B |
MRTXEURMIRATI THERAPEUTICS INC | $46.0B |
PENPENUMBRA INC | $45.4B |
EXASEXACT SCIENCES CORP | $39.9B |
SGENUSDSEAGEN INC | $39.0B |
—SIERRA ONCOLOGY INC | $37.7B |
MIRMMIRUM PHARMACEUTICALS INC | $36.7B |
EHCENCOMPASS HEALTH CORP | $35.7B |
WRBYWARBY PARKER INC | $35.1B |
SRPTSAREPTA THERAPEUTICS INC | $33.4B |
NVV1NOVAVAX INC | $33.0B |
KYMRKYMERA THERAPEUTICS INC | $32.0B |
ARVNARVINAS INC | $30.8B |
CNMDCONMED CORP | $30.1B |
CYTK 4 11/15/26CYTOKINETICS INC | $29.3B |
WSTWEST PHARMACEUTICAL SVSC INC | $28.4B |
CVETUSDCOVETRUS INC | $28.1B |
MDGLMADRIGAL PHARMACEUTICALS INC | $26.8B |
NVTA1EURINVITAE CORP | $26.5B |
ACCDEURACCOLADE INC | $26.4B |
—ABCAM PLC | $26.2B |
XENEXENON PHARMACEUTICALS INC | $25.8B |
PHRPHREESIA INC | $25.0B |
TVTXTRAVERE THERAPEUTICS INC | $24.5B |
PRTAPROTHENA CORP PLC | $24.3B |
HCATHEALTH CATALYST INC | $23.9B |
—PROMETHEUS BIOSCIENCES INC | $23.6B |
AURAAURA BIOSCIENCES INC | $22.2B |
BMRNBIOMARIN PHARMACEUTICAL INC | $20.4B |
LFSTLIFESTANCE HEALTH GROUP INC | $20.2B |
—CINCOR PHARMA INC | $18.1B |
RLAYRELAY THERAPEUTICS INC | $18.0B |
LUNGPULMONX CORP | $17.4B |
—OLINK HLDG AB | $17.4B |
DVAXDYNAVAX TECHNOLOGIES CORP | $17.2B |
—INTERSECT ENT INC | $15.4B |
—MERSANA THERAPEUTICS INC | $15.0B |
LEGNLEGEND BIOTECH CORP | $14.9B |
COLLCOLLEGIUM PHARMACEUTICAL INC | $14.8B |
RIGLUSDRIGEL PHARMACEUTICALS INC | $14.7B |
AMRNAMARIN CORP PLC | $14.5B |
NVCRNOVOCURE LTD | $14.5B |
RYTMRHYTHM PHARMACEUTICALS INC | $14.3B |
ANABANAPTYSBIO INC | $13.9B |
GHGUARDANT HEALTH INC | $13.2B |
AMLXAMYLYX PHARMACEUTICALS INC | $12.8B |
VERVVERVE THERAPEUTICS INC | $11.5B |
290ACHINOOK THERAPEUTICS INC | $11.5B |
—AMRYT PHARMA PLC | $10.8B |
FULCFULCRUM THERAPEUTICS INC | $10.3B |
—ORION ACQUISITION CORP | $9.8B |
AM6AMICUS THERAPEUTICS INC | $9.6B |
AUPHAURINIA PHARMACEUTICALS INC | $9.5B |
GRPHGRAPHITE BIO INC | $9.1B |
AKROAKERO THERAPEUTICS INC | $9.0B |
—GAMIDA CELL LTD | $8.9B |
SPROSPERO THERAPEUTICS INC | $8.6B |
XLOXILIO THERAPEUTICS INC | $8.4B |
—EPIZYME INC | $8.4B |
MGNXMACROGENICS INC | $8.2B |
GOSS 5 06/01/27GOSSAMER BIO INC | $7.7B |
—ATHIRA PHARMA INC | $7.5B |
—FUSION PHARMACEUTICALS INC | $7.4B |
CMPXCOMPASS THERAPEUTICS INC | $7.3B |
CGEMCULLINAN ONCOLOGY INC | $6.8B |
MREOMEREO BIOPHARMA GROUP PLC | $6.8B |
LPTXEURLEAP THERAPEUTICS INC | $6.3B |
EDAEDAP TMS S A | $5.9B |
NKTXNKARTA INC | $5.8B |
DSGNDESIGN THERAPEUTICS INC | $5.6B |
Page 1 of 2Next